Several synthetic lethality screens have been performed on KRAS mutant cancer cell lines to determine potential targets, and results have frequently included genes important in cell cycle progression or mitosis, such as CDK1 [36], cyclin A2 [37], PLK1 [37], and CDC6 [38]. Here, KRAS is linked to cancer.